VANCOMYCIN AUC: MIC VERSUS TROUGH MONITORING IN PATIENTS RECEIVING CRRT

被引:0
|
作者
Martens, Mycah [1 ]
Nixon, Alexander [2 ]
Cooper-Johnson, Kaitlin [3 ]
Juul, Janelle [4 ]
Herrmann, David [1 ]
Tchen, Stephanie [1 ]
Feih, Joel [3 ]
机构
[1] Froedtert Hosp, Wauwatosa, WI USA
[2] Miami Valley Hosp, Milwaukee, WI USA
[3] Froedtert & Med Coll Wisconsin, Froedtert Hosp, Milwaukee, WI USA
[4] Froedtert Lutheran Mem Hosp, MILWAUKEE, WI USA
关键词
D O I
10.1097/01.ccm.0001102580.41699.3a
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Trough-guided Versus AUC/MIC-Guided Vancomycin Monitoring: A Cost Analysis
    Morales, Ronaldo
    Tiguman, Gustavo Magno Baldin
    Juodinis, Vanessa D'Amaro
    Santos, Isabela Cristina Pinheiro de Freitas
    Leite, Fernanda Soares
    Vercelino, Jucara Guicardi
    de Lima, Bruna Diniz
    Barbosa, Livia Maria Goncalves
    CLINICAL THERAPEUTICS, 2022, 44 (09) : E91 - E96
  • [2] Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia
    Beccari, Mario V.
    Seabury, Robert W.
    Mogle, Bryan T.
    Kufel, Wesley D.
    Miller, Christopher D.
    Steele, Jeffrey M.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (05) : 729 - 733
  • [3] Association of vancomycin-induced acute kidney injury with trough versus AUC monitoring in patients receiving extended durations of therapy
    Pitcock, C. Tyler
    Schadler, Aric
    Burgess, David S.
    Burgess, Donna R.
    Cotner, Sarah E.
    Van Hoose, Jeremy
    Gregory, Eric R.
    Wallace, Katie L.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2023, 3 (01):
  • [4] USE OF AUC: MIC MONITORING TO IMPROVE VANCOMYCIN DOSING IN PEDIATRIC CF PATIENTS
    McDade, E. J.
    Kam, C.
    Hiatt, P.
    Ruiz, F. E.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S389 - S389
  • [5] Balancing Vancomycin Efficacy and Nephrotoxicity: Should We Be Aiming for Trough or AUC/MIC?
    Karisma Patel
    Ashley S. Crumby
    Holly D. Maples
    Pediatric Drugs, 2015, 17 : 97 - 103
  • [6] Balancing Vancomycin Efficacy and Nephrotoxicity: Should We Be Aiming for Trough or AUC/MIC?
    Patel, Karisma
    Crumby, Ashley S.
    Maples, Holly D.
    PEDIATRIC DRUGS, 2015, 17 (02) : 97 - 103
  • [7] The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review
    Tkachuk, Stacey
    Collins, Kyle
    Ensom, Mary H. H.
    PEDIATRIC DRUGS, 2018, 20 (02) : 153 - 164
  • [8] The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review
    Stacey Tkachuk
    Kyle Collins
    Mary H. H. Ensom
    Pediatric Drugs, 2018, 20 : 153 - 164
  • [9] Vancomycin Trough Concentration Poorly Characterizes AUC: Is It Time to Transition to AUC-Based Vancomycin Monitoring?
    Seabury, Robert W.
    Stoessel, Andrew M.
    Steele, Jeffrey M.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (10) : 926 - 927
  • [10] Therapeutic drug monitoring of vancomycin by AUCτ-MIC ratio in patients with chronic kidney disease
    Khoei, Ahmad
    Soltani, Rasool
    Emami, Jaber
    Badri, Shirinsadat
    Taheri, Shahram
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2019, 14 (01) : 84 - 92